April19 is a drug development company that integrates AI with computational chemistry to design and develop psychedelic-inspired compounds for various therapeutic indications, including neurodegenerative disorders and healthy longevity. The company focuses on expanding the utility of psychedelics beyond mental health by optimizing their pharmacology.

April19 Discovery Inc

April19 Discovery | 552 followers on LinkedIn. AI-driven psychedelic drug discovery | We use next-gen machine learning to find novel psychedelic drug compounds. Classical (first-generation) psychedelics have never been optimized to treat any disease and so we aim to design compounds with the optimal risk-benefit ratio in various indications. Beyond mental health, we focus on neurodegeneration and neural injuries, increasing brain longevity and extending human mental healthspan.

AI-driven drug discovery

Richard Dallaway

I give business owners more hours in the day - by outsourcing your business support to me creating time for YOU to smash those goals. Concierge |…

Jill Hartery

Founder & Business Lawyer at Britannia Law Corporation

Miles Gelmon

April19 Discovery

Ten years of cognitive decline reversed, cognitive scores increased by 57%, Alzheimer's diagnosis formally retracted... What a magnificent display of the power of psychedelics in treating neurodegenerative disorders. We are feeling truly blessed to see this hands-on confirmation that our development efforts are going very much in the right direction. We thank Chelsea R. and Cody Shirk from Spannr - End-to-End Longevity. who had wisely seen the potential of the compounds we are pursuing for treating neurodegeneration and advancing the quest for healthy longevity. And of course, Adam Tapp , the hero of this story, and of our time. Alzheimer's Society Alzheimer's Association® Mapping Alzheimer's Alzheimer's Readiness Project Alzheimer's Disease Research Alzheimer Nederland Alzheimer Society of Ireland Alzheimer's Association WNY Chapter Events Alzheimer's Products Australia American Alzheimer's Research Organization Alzheimer's Family Center Alzheimer's Drug Discovery Foundation Alzheimer's Care Specialists Alzheimer Society of Canada Société Alzheimer D. Alzheimers Family Organization #drugdiscovery #drugdevelopment #Alzheimer #neurodegeneration # #development #longevity #lifespan

Watch our CEO's lecture on using psychedelics in dementia treatment! (currently Czech only - comment if interested in English subtitles) #psychedelics #dementia #longevity #neurodegeneration #psychedelictherapy #Alzheimers

To our Czech followers - do not miss April19 CEO Jáchym Fibír giving a lecture about the development of revolutionary #psychedelic therapies for #neurodegeneration and #dementia at the Faculty of Philosophy, Charles University in Prague!

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 10:02 AM	3a594835
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 10:02 AM	6e6fa67d
crunchbase trigger	general	Nov 12, 2024 10:02 AM	d8039251
crunchbase profile	general
li profile	general	Nov 12, 2024 10:02 AM	299821ef
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 10:02 AM	098d5715
news basic	general	Nov 12, 2024 10:02 AM	fa7c3e4e
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

APRI

AI:APRIL19

April19 Discovery Inc